NuView Life Sciences is Drug Discovery in United States that focus on cancer biomarker platform integrates business. Founded in 2005. They cover business area such as provider, early stage detection, breast and prostrate cancer, an in vitro diagnostic kit, in-vivo diagnostic imaging, cancerous cell, voided urine, bio, -fluid, surgeon, medical practitioner, patient outcome, healthcare cost.
2005
( 19 years old in 2024 )
Cancer Biomarker Platform Integrates
-
1389 Center Drive
Suite 200
Park City, UT 84098
United States
Private
providerearly stage detectionbreast and prostrate canceran in vitro diagnostic kitin-vivo diagnostic imagingcancerous cellvoided urinebio-fluidsurgeonmedical practitionerpatient outcomehealthcare cost
* We use standard office opening hours in near NuView Life Sciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NuView Life Sciences is Drug Discovery business from United States that founded in 2005 (19 years old in 2024), NuView Life Sciences business is focusing on Cancer Biomarker Platform Integrates.
NuView Life Sciences headquarter office and corporate office address is located in 1389 Center Drive Suite 200 Park City, UT 84098 United States.
NuView Life Sciences was founded in United States.
In 2024, NuView Life Sciences is currently focus on cancer biomarker platform integrates sector.
Above is snippet of Google Trends for "cancer biomarker platform integrates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NuView Life Sciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
